Anti-Vinculin Antibodies (Anti-Vinculin)
Autoantibodies targeting vinculin, an essential cytoplasmic actin-binding protein in enteric neurons and interstitial cells of Cajal (ICC).
Standard vs. Optimal Reference RangesRatio
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
<1.60 (optical density ratio)
General reference distribution across unselected commercial populations.
<1.00 (negative)
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Generated via molecular mimicry against bacterial CdtB; destroys enteric pacemaker cells that govern the Migrating Motor Complex (MMC).
Differential Diagnosis
Elevated Levels (Anti-Vinculin High)
- •Enteric neuromuscular autoimmune damage
- •Disrupted Migrating Motor Complex (MMC)
- •Chronic recurrent SIBO / Post-infectious IBS
Low Levels (Anti-Vinculin Low)
- •Normal enteric pacemaker innervation
- •Intact phase-III MMC sweeping contractions
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for Anti-Vinculin
- Targeted organ system imaging or functional dynamic testing related to enteric neuropathy & migrating motor complex
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Anti-Vinculin Antibodies - The New England Journal of Medicine (2021). PMID: 33990124
- [2]Anti-Vinculin Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35222901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Anti-Vinculin Antibodies (Anti-Vinculin) into overall healthspan optimization.